MEDVi is a telehealth provider offering medically supervised weight loss programs using GLP-1 medications such as Semaglutide and Tirzepatide. The platform connects patients with independent physicians who create personalized treatment plans tailored to individual needs. MEDVi simplifies the process with all-inclusive pricing, no membership fees, and free shipping. Designed for convenience, the service does not require insurance and starts at $179. MEDVi supports effective fat loss through accessible, clinically guided care.
Key Details:
- Location: The company is headquartered in Newark, Delaware, United States.
- Founders: -
- Foundation Date: The company was established in the year 2023.